Close navigation

Emerging glioblastoma treatments

Using Immunotherapy to treat glioblastoma

Immunotherapy, which uses substances to enhance or subdue your immune system to help your body fight the tumour, is also showing some promise, such as the cancer vaccine DCVax®.

DCVax ® is a personalised cancer vaccine that is made from each patient's own dendritic cells. (Dendritic cells are a type of immune cell that help the body's immune system recognise and attack tumour cells.)

In May 2018, interim results from a clinical trial showed increased overall survival for patients with glioblastoma. However, as of June 2018, it's not currently available on the NHS, and the trial, though ongoing, is not recruiting any more people. It may be possible to access it privately and you may have to go abroad for the initial treatment. You will need to have a sample of your tumour flash frozen. Speak to your healthcare team if you are interested.

Find out more about immunotherapy

Using Tumour Treating Fields (TTF) to treat glioblastoma

Also known as Optune ®, TTF is a relatively new, non-invasive technique for adults with glioblastoma. It uses alternating electrical fields, delivered via a set of adhesive patches worn like a skull cap, to disrupt tumour cell division, or cause cell death. This helps to prevent the tumour from growing or spreading so quickly.

It's not currently available through the NHS.

Find out more about TTF

Get support

If you need someone to talk to or advice on where to get help, we offer a wide range of inclusive and accessible support services for everyone affected by a brain tumour.

Share your experiences and help create change

By taking part in our Improving Brain Tumour Care surveys and sharing your experiences, you can help us improve treatment and care for everyone affected by a brain tumour.

If you have further questions, need to clarify any of the information on this page, or want to find out more about research and clinical trials, please contact our team:

Support and Information Services

0808 800 0004 (free from landlines and mobiles)

Phone lines open Mon-Fri, 09:00-17:00

You can also join our active online community - Join our online support groups.